Bifidobacterium lactis Bb12 Enhances Intestinal Antibody Response in Formula-Fed Infants.

Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine.

Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.

Lactobacilli and Bifidobacteria Promote Immune Homeostasis by Modulating Innate Immune Responses to Human Rotavirus.

Probiotics in the management of atopic eczema.

Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

Specific probiotics in enhancing maturation of IgA responses in formula-fed infants.

Clinical trials prove the safety and efficacy of the probiotic strain Bifidobacterium Bb12 in follow-up formula and growing-up milks.

Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants.